Be SunAWARE to Prevent Melanoma

The K-12 curriculum developed by the Children’s Melanoma Prevention Foundation (CMPF) is now a part of the MRF Education Institute. Learn more and become SunAWARE today!




New Education Materials

A new animated patient video has been added to the “You and Melanoma” learning module. Click here to learn about genetic testing in melanoma and how it can affect treatment decisions.


MRF Advocates Take Action


MRF Advocates Take Action

MRF Advocates are a powerful voice for the melanoma community. View our current legislative priorities and learn how you can get involved today!




MRF Virtual Advocacy Days

Register today to join melanoma advocates from across the United States to be the voice of the melanoma community on Capitol Hill on March 7-11, 2022!

Ocular Melanoma

Ocular Melanoma Patients: Register Today!

Ocular Melanoma

Ocular Melanoma Patients: Register Today!

Join the first patient-powered, patient-reported ocular melanoma patient registry and help us find a cure!

Research and Science

Apply for 2022 Research Funding

Research and Science

Apply for 2022 Research Funding

The 2022 MRF Research Awards Request for Proposals (RFP) is now available! Applications will be accepted beginning on January 10, 2022. Learn more and begin your application today!

The MRF’s mission is to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community.

Melanoma is the deadliest form of skin cancer.

Melanoma claims the lives of over 7,000 Americans every year.

Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.

9 out of 10 cases are considered to be preventable.

Funding Melanoma Research

Funding from The MRF has resulted in:

clinical trials

22 Clinical trials


83 Grants with new collaborations

204 Publications


409 Presentations

Recent Funded Research Recipients

Formulation and Preclinical Testing of an HLA-Engineered Neoantigen Vaccine for Melanoma
Clinical and genetic predictors of skin toxicity in mucosal melanoma treated with immune checkpoint inhibitors
High-Resolution In Vivo Image-guided Molecular Profiling of Melanomas
The effects of methotrexate treatment on melanoma progression

Latest News

The MRF is proud to share the following press release from the Congressionally Directed Medical Research Program announcing MRF Board
Guest blog post by Martin McMahon, PhD, Senior Director of Preclinical Research, Principal Investigator at Huntsman Cancer Institute. Dr. McMahon
Guest blog post by Richard K. Lodwick, OD: As I explain to most every patient, the view into the eye
Guest blog post by ocular melanoma patient and advocate Karen Kaludov: When I was in college, a doctor told me

Optimize Your Treatment

Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients?

Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.


Shop to Support MRF.

Grab some merch to support our mission to eradicate melanoma by accelerating medical research while educating to and advocating for the melanoma community.




The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.